<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="systematic-review">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Vet. Sci.</journal-id>
<journal-title>Frontiers in Veterinary Science</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Vet. Sci.</abbrev-journal-title>
<issn pub-type="epub">2297-1769</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fvets.2022.938629</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Veterinary Science</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of low-grade inflammation caused by gut microbiota disturbances with osteoarthritis: A systematic review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Xiang</surname> <given-names>Wu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1755383/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ji</surname> <given-names>Bingjin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jiang</surname> <given-names>Yiqin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Xiang</surname> <given-names>Han</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Rehabilitation, Beibei Traditional Chinese Medical Hospital</institution>, <addr-line>Chongqing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Radiology, Daping Hospital, Army Medical University</institution>, <addr-line>Chongqing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Isaac Karimi, Razi University, Iran</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Vinod R. M. T. Balasubramaniam, Monash University Malaysia, Malaysia; Mingxuan Zheng, Xuzhou Medical University, China</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Han Xiang <email>903274184&#x00040;qq.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Comparative and Clinical Medicine, a section of the journal Frontiers in Veterinary Science</p></fn></author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>938629</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>05</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>08</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Xiang, Ji, Jiang and Xiang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Xiang, Ji, Jiang and Xiang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license></permissions>
<abstract>
<sec>
<title>Background</title>
<p>Currently, many studies have been published on the relationship between the gut microbiome and knee osteoarthritis. However, the evidence for the association of gut microbiota with knee osteoarthritis has not been comprehensively evaluated.</p></sec>
<sec>
<title>Objective</title>
<p>This review aimed to assess existing results and provide scientific evidence for the association of low-grade inflammation caused by gut microbiota disturbances with knee osteoarthritis.</p></sec>
<sec>
<title>Methods</title>
<p>This study conducted an extensive review of the current literature using four databases, PubMed, EMBASE, Cochrane Library and Web of Science before 31 December 2021. Risk of bias was determined using ROBINS and SYRCLE, and quality of evidence was assessed using GRADE and CAMADARES criteria. Twelve articles were included.</p></sec>
<sec>
<title>Results</title>
<p>Studies have shown that a high-fat diet leads to a disturbance of the gut microbiota, mainly manifested by an increase in the abundance of Firmicutes and Proteobacteria, a decrease in Bacteroidetes, and an increase in the Firmicutes/ Bacteroidetes ratio. Exercise can reverse the pattern of gain or loss caused by high fat. These changes are associated with elevated levels of serum lipopolysaccharide (LPS) and its binding proteins, as well as various inflammatory factors, leading to osteoarthritis (OA).</p></sec>
<sec>
<title>Conclusion</title>
<p>This systematic review shows that a correlation between low-grade inflammation caused by gut microbiota disturbances and severity of knee osteoarthritis radiology and dysfunction. However, there was a very small number of studies that could be included in the review. Thus, further studies with large sample sizes are warranted to elucidate the association of low-grade inflammation caused by gut microbiota disturbances with osteoarthritis, and to explore the possible mechanisms for ameliorating osteoarthritis by modulating gut microbiota.</p></sec></abstract>
<kwd-group>
<kwd>low-grade inflammation</kwd>
<kwd>gut microbiota</kwd>
<kwd>gut microbiota disturbances</kwd>
<kwd>osteoarthritis</kwd>
<kwd>systematic review</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="61"/>
<page-count count="08"/>
<word-count count="5280"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Osteoarthritis (OA) is the most common musculoskeletal disease and one of the leading causes of disability (<xref ref-type="bibr" rid="B1">1</xref>). Epidemiological surveys show that more than 320 million people worldwide suffer from OA, and the prevalence is higher in women than men. Traditionally, mechanical and genetic factors have been considered important causes of OA (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). However, emerging evidence suggests that low-grade inflammation plays an important role in the development of OA (<xref ref-type="bibr" rid="B4">4</xref>), and this inflammatory state is closely related to the gastrointestinal microbiota (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>The gastrointestinal microbiota refers to the sum of all genetic material and its metabolites of all microbiota present in the gut (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). The gut microbiota plays an important role in maintaining the body&#x00027;s homeostasis, which underlies human physiology, immune system development, digestion, fat storage, regulation of angiogenesis, behavior, development, and detoxification responses. The human gut microbiota is mainly composed of Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria and Verrucobacterium. Among them, Bacteroidetes and Firmicutes account for more than 98% of the total number of intestinal symbiotic flora of more than 70 species (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Studies have shown that a variety of diseases are associated with specific bacterial sequences and alterations and disturbances in the composition of the microbiota (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). At the same time, the gut microbiota plays a key role in the development and function of the immune system, as well as in allergic and inflammatory responses (<xref ref-type="bibr" rid="B12">12</xref>&#x02013;<xref ref-type="bibr" rid="B15">15</xref>). Alterations in the microbiome activate the innate immune system, leading to increased pro-inflammatory cytokines, and these local and systemic low-grade inflammations contribute to the development and progression of OA (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>At present, there are more and more studies on the correlation between low-grade inflammation caused by intestinal flora disturbance and OA. It is difficult to draw conclusions about the consistency of the association due to different study designs and assessment methods, so it is unclear whether low-grade inflammation due to disturbances in the gut microbiota has a different effect on OA. Given the high prevalence of OA and its significant socioeconomic burden, it is important to explore the impact of low-grade inflammation caused by gut microbiota disturbances on OA.</p></sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec>
<title>Search strategy</title>
<p>We searched comprehensively for articles published before 31 December 2021 using four electronic medical databases (PubMed, EMBASE, Cochrane Library and Web of Science). Studies were identified using the search terms &#x0201C;(&#x00027;gut microbiota&#x00027; or &#x00027;microbiome&#x00027; or &#x00027;microbiota&#x00027; or &#x00027;gut&#x00027;) and (&#x00027;Osteoarthritis&#x00027; or &#x00027;arthritis&#x00027; or &#x00027;KOA&#x00027; or &#x00027;OA&#x00027;) and (&#x00027;Inflammation&#x00027;)&#x0201D;.</p></sec>
<sec>
<title>Selection criteria</title>
<p>Inclusion criteria: (1) clinical and basic research with any level of evidence; (2) English-language articles published in peer-reviewed journals; (3) studies on the association of low-grade inflammation caused by gut microbial imbalances with OA, and OA Pathogenesis or related-symptoms. Exclusion criteria: (1) studies with missing data; (2) studies with duplication and poor scientific method; (3) abstracts, case reports, conference reports, reviews, editorials, and expert opinions were excluded.</p></sec>
<sec>
<title>Literature screening and data extraction</title>
<p>Two investigators (WX and HX) independently searched, selected relevant articles according to the inclusion and exclusion criteria, read the full text, and extracted data from the final included literature. Any disagreements were resolved by an experienced systematic reviewer (BJJ). Differences in data extraction are resolved by consensus.</p>
<p>After extraction, the data was considered of heterogenous nature both by study design, measure, and method of assessment. Therefore, a descriptive analysis approach was preferred to a metanalysis. <xref ref-type="fig" rid="F1">Figure 1</xref> for details.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Literature search and screening flowchart.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fvets-09-938629-g0001.tif"/>
</fig></sec>
<sec>
<title>Risk of bias assessment</title>
<p>ROBINS was used to assess the risk of bias in non-randomized clinical studies (<xref ref-type="bibr" rid="B18">18</xref>), and RoB 2.0 (<xref ref-type="bibr" rid="B19">19</xref>) was used to assess the risk of bias in randomized clinical studies. Risk of bias in preclinical studies was assessed using SYRCLE (<xref ref-type="bibr" rid="B20">20</xref>). WX and HX conduct evaluations independently, and any disagreements are resolved by consensus.</p></sec>
<sec>
<title>Study quality assessment</title>
<p>The quality of clinical studies (<italic>n</italic> = 6) was assessed using the GRADE method (<xref ref-type="bibr" rid="B21">21</xref>) and each study was classified as &#x00027;low&#x00027;, &#x00027;moderate&#x00027; or &#x00027;high&#x00027;. All studies were ranked &#x00027;moderate&#x00027; or &#x00027;high&#x00027;. The quality of preclinical studies (<italic>n</italic> = 6) was assessed using the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (CAMADARES) checklist (<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>) (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Each study was scored on a scale from 0 to 10 points, and the overall quality of included studies was moderate (mean CAMADARES score 4.17, range 4&#x02013;5). WX and HX conduct evaluations independently, and any disagreements are resolved by consensus.</p></sec></sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Study characteristics</title>
<p>The final analysis included 12 studies, 6 of which were animal studies (<xref ref-type="bibr" rid="B24">24</xref>&#x02013;<xref ref-type="bibr" rid="B29">29</xref>) and 6 were clinical studies (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B30">30</xref>&#x02013;<xref ref-type="bibr" rid="B34">34</xref>). Regarding clinical trials, 4 were non-randomized observational studies (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>) and 2 were randomized clinical trials (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). The main characteristics of the included studies are reported in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>The main findings of the included studies.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Source</bold></th>
<th valign="top" align="left"><bold>Total No</bold>.</th>
<th valign="top" align="left"><bold>Sex</bold></th>
<th valign="top" align="left"><bold>Age Mean(SD)</bold></th>
<th valign="top" align="left"><bold>Assessment of OA</bold></th>
<th valign="top" align="left"><bold>Assessment of Inflammation</bold></th>
<th valign="top" align="left"><bold>Main Findings</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Huang et al. (<xref ref-type="bibr" rid="B30">30</xref>)</td>
<td valign="top" align="left">25 humans</td>
<td valign="top" align="left">18 female</td>
<td valign="top" align="left">62.4(15.8)</td>
<td valign="top" align="left">JSN score, NHANES-I and WOMAC score</td>
<td valign="top" align="left">LPS and LBP</td>
<td valign="top" align="left">LPS is important in the pathogenesis and severity of KOA.</td>
</tr>
<tr>
<td valign="top" align="left">Lei et al. (<xref ref-type="bibr" rid="B31">31</xref>)</td>
<td valign="top" align="left">461 humans</td>
<td valign="top" align="left">241 female</td>
<td valign="top" align="left">Lcs group: 66.5(5.2) Placebo group: 67.2(4.8)</td>
<td valign="top" align="left">WOMAC score and VAS score</td>
<td valign="top" align="left">hs-CRP</td>
<td valign="top" align="left">LcS can improve OA by reducing serum hs-CRP levels.</td>
</tr>
<tr>
<td valign="top" align="left">Huang et al. (<xref ref-type="bibr" rid="B32">32</xref>)</td>
<td valign="top" align="left">431 humans</td>
<td valign="top" align="left">all female</td>
<td valign="top" align="left">54.7(5.64)</td>
<td valign="top" align="left">uCTX-II, JSW and JSN</td>
<td valign="top" align="left">LBP, sTLR4 and IL-6</td>
<td valign="top" align="left">Plasma LBP and sTLR4 correlate with KOA progression, suggesting a role for systemic low-grade inflammation in KOA pathogenesis.</td>
</tr>
<tr>
<td valign="top" align="left">Ulici et al. (<xref ref-type="bibr" rid="B24">24</xref>)</td>
<td valign="top" align="left">50 mice</td>
<td valign="top" align="left">all male</td>
<td valign="top" align="left">Younger 12-18 weeks, older 37-48 weeks</td>
<td valign="top" align="left">ACS, osteophyte size and synovial hyperplasia</td>
<td valign="top" align="left">IL-6, LPS and LBP</td>
<td valign="top" align="left">Factors related to the gut microbiota promote the development of OA after joint injury.</td>
</tr>
<tr>
<td valign="top" align="left">Boer et al. (<xref ref-type="bibr" rid="B5">5</xref>)</td>
<td valign="top" align="left">1427 humans</td>
<td valign="top" align="left">821 female</td>
<td valign="top" align="left">56.9 (5.9)</td>
<td valign="top" align="left">knee WOMAC pain scores and Kellgren-Lawrence radiographic OA severity scores</td>
<td valign="top" align="left">the amount of effusion of knee</td>
<td valign="top" align="left">Abundance of Streptococcus species is associated with increased knee pain and this association is driven by local inflammation in the knee joint. The microbiome is a possible therapeutic target for KOA.</td>
</tr>
<tr>
<td valign="top" align="left">Huang et al. (<xref ref-type="bibr" rid="B26">26</xref>)</td>
<td valign="top" align="left">42 mice</td>
<td valign="top" align="left">6 male and<break/> 6 female</td>
<td valign="top" align="left">8 weeks</td>
<td valign="top" align="left">OARSI score, Safranin O score and Synovitis score</td>
<td valign="top" align="left">G-CSF, IL-1&#x003B2;, IL-6, IL-10, IL-17, IP-10, MCP-1, MIP-1&#x003B1; and LPS</td>
<td valign="top" align="left">Changes in the gut microbiota can promote the development of OA.</td>
</tr>
<tr>
<td valign="top" align="left">Guan et al. (<xref ref-type="bibr" rid="B25">25</xref>)</td>
<td valign="top" align="left">54 mice</td>
<td valign="top" align="left">27 male and 27 female</td>
<td valign="top" align="left">8 weeks</td>
<td valign="top" align="left">DXA, Micro-CT and OARSI score</td>
<td valign="top" align="left">MMP-13</td>
<td valign="top" align="left">Antibiotic-induced gut dysbiosis reduces serum lipopolysaccharide levels and inflammatory response, resulting in decreased MMP-13 expression and improved OA.</td>
</tr>
<tr>
<td valign="top" align="left">Jhun et al. (<xref ref-type="bibr" rid="B27">27</xref>)</td>
<td valign="top" align="left">36 mice</td>
<td valign="top" align="left">male rats</td>
<td valign="top" align="left">6 weeks</td>
<td valign="top" align="left">modified Mankin score and Matrix staining</td>
<td valign="top" align="left">IL-1&#x003B2;, LPS, MCP-1, CCR-2, PPAR-&#x003B3;, GABA, MMP3, TIMP1, TIMP3, SOX9, COL2A1 and IL-10</td>
<td valign="top" align="left">Intestinal damage and inflammation were improved by L. rhamnosus and own the therapeutic potential in OA.</td>
</tr>
<tr>
<td valign="top" align="left">Li KF et al. (<xref ref-type="bibr" rid="B28">28</xref>)</td>
<td valign="top" align="left">54 mice</td>
<td valign="top" align="left">all male</td>
<td valign="top" align="left">8weeks</td>
<td valign="top" align="left">Mankin score and cartilage thickness</td>
<td valign="top" align="left">LPS, TLR-4 and MMP-13</td>
<td valign="top" align="left">Exercise can relieve of OA and chronic inflammation, which is a potential therapeutic way for obesity-related OA.</td>
</tr>
<tr>
<td valign="top" align="left">Dunn et al. (<xref ref-type="bibr" rid="B33">33</xref>)</td>
<td valign="top" align="left">75 humans and 23 mice</td>
<td valign="top" align="left">48 women and 23 male mice</td>
<td valign="top" align="left">11 weeks</td>
<td valign="top" align="left">OARSI score</td>
<td valign="top" align="left">LPS and LBP</td>
<td valign="top" align="left">Reveal a microbial DNA signature in human and mouse cartilage and identify strain-specific signatures within mouse cartilage that mirror human patterns.</td>
</tr>
<tr>
<td valign="top" align="left">Won et al. (<xref ref-type="bibr" rid="B29">29</xref>)</td>
<td valign="top" align="left">mice</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">12 weeks</td>
<td valign="top" align="left">OARSI score, synovitis score and Osteophyte size</td>
<td valign="top" align="left">TLR-2, TLR-4, LBP and CD14</td>
<td valign="top" align="left">LBP and CD14 are necessary for the exacerbation of posttraumatic OA cartilage destruction resulting from low-grade inflammation.</td>
</tr>
<tr>
<td valign="top" align="left">Loeser et al. (<xref ref-type="bibr" rid="B34">34</xref>)</td>
<td valign="top" align="left">92 humans</td>
<td valign="top" align="left">69 female</td>
<td valign="top" align="left">Cases 73.7(6.9) and controls 70.8(6.4)</td>
<td valign="top" align="left">WOMAC pain score, AUSCAN hand pain score, ACS score Safranin-O score and osteophytes</td>
<td valign="top" align="left">LPS and LBP</td>
<td valign="top" align="left">The increasement of serum LPS levels may contribute to development of OA associated with obesity.</td>
</tr>
</tbody>
</table><table-wrap-foot>
<p>uCTX-II, urinary (u) C-telopeptide of Type II collagen; JSW, radiographic tibiofemoral joint space width; JSN, joint space narrowing; WOMAC, Western Ontario McMaster Universities; VAS, Visual Analog Scale/Score; LPS, lipopolysaccharide; LBP, lipopolysaccharide-binding protein; TLR2, Toll-like receptor 2; sTLR4, soluble Toll-like receptor 4; TLR4, Toll-like receptor 4; IL-1&#x003B2;, interleukin-1&#x003B2;; IL-6, interleukin-6; IL-10, interleukin-10; IL-17, Interleukin 17; MCP-1, Monocyte chemoattractant protein-<italic>1</italic>; CCR2: Recombinant Chemokine C-C-Motif Receptor 2; MMP3, matrix metallopeptidase 3; MMP-13: matrix metalloproteinase-13; GABA, &#x003B3;-aminobutyric acid; PPAR-&#x003B3;, peroxisome proliferator-activated receptor &#x003B3;; TIMP1, tissue inhibitor of metalloproteinases <italic>1</italic>; TIMP3, tissue inhibitor of metalloproteinases <italic>3</italic>; MLI, Meniscal/Ligamentous Injury; METS, Metabolic Syndrome; OA, Osteoarthritis; KOA, knee Osteoarthritis; ACS, scores for articular cartilage structure; Lcs, Lactobacillus casei Shirota; hs-CRP, high-sensitivity C-reactive protein; OARSI, the Osteoarthritis Research Society International; GCSF, Granulocyte-colony stimulating factor; IP-10, Interferon Gamma-Induced Protein 10; MIP-1&#x003B1;, Macrophage Inflammatory Protein 1&#x003B1;; CD14, cluster of differentiation 14; AUSCAN, The AUStralian CANadian Osteoarthritis Hand Index;SOX9, SRY-related high mobility group-box gene9; COL2A1, Type II collagen fiber &#x003B1;1 gene; DXA, Dual Energy X-ray Bone Densitometry.</p>
</table-wrap-foot>
</table-wrap>
<p>Most studies used 16S ribosomal RNA (rRNA) gene sequencing to examine gut microbiota and Enzyme-linked immunosorbent assay (ELISA) to measure inflammatory markers. Meanwhile, most studies assessed radiographic or symptom severity of OA using Western Ontario McMaster Universities (WOMAC) score, Visual Analog Scale (VAS) score, scores for articular cartilage structure (ACS) score, the Osteoarthritis Research Society International (OARSI) score, synovitis score and Osteophyte size. Overall, various studies have suggested that there is a certain relationship between inflammation caused by intestinal flora disturbance and OA.</p></sec>
<sec>
<title>Effects of diet, exercise or probiotics on gut microbiota</title>
<p>High-fat diet leads to gut microbiota disturbances and is a common model of low-grade inflammation (<xref ref-type="bibr" rid="B35">35</xref>). Firmicutes, Bacteroidetes and Proteobacteria are the three major phyla of the gut microbiota (<xref ref-type="bibr" rid="B28">28</xref>). High-fat diet cause disturbance of the gut microbiota, increase endotoxin-producing bacteria, and decrease bacteria protecting the intestinal barrier, thereby enhancing bone destruction on OA in mice. It is mainly manifested by an increase in the abundance of Firmicutes and Proteobacteria, but a decrease in Bacteroidetes, and an increase in the Firmicutes/Bacteroidetes ratio (<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>Exercise reverses high fat diet-induced gut microbiota disturbances, manifested by decreased abundances of Firmicutes and Proteobacteria, increased abundance of Bacteroidetes, and decreased Firmicutes/Bacteroidetes ratios. At the family level, exercise reversed the unclassified Bacteroidetes, Lachnospira, Desulfovibrio, Ruminococci, Lactobacillus, Prevotaceae, Peptostreptococcus, Bifidobacterium, and Staphylococcus (<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>Two studies suggest that probiotic supplementation reduces intestinal damage and inflammation, and has great potential in the treatment of osteoarthritis (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B31">31</xref>).</p></sec>
<sec>
<title>The influence of intestinal flora disturbance on OA</title>
<p>Intestinal microbial disturbances increase intestinal permeability and cause low-grade inflammation throughout the body, thereby aggravating OA. By transplanting human microorganisms into mice, it was found that the abundance of Fusobacterium and Enterococcus faecalis in the transplanted mice increased, but the abundance of Ruminococcus decreased, the average systemic concentration of inflammatory markers increased, and the intestinal increased permeability is associated with more severe OA (<xref ref-type="bibr" rid="B26">26</xref>). At the same time, the serum estrogen level in OA rats was significantly decreased, which was correlated with the significant increase in LPS. In Lactobacillus rhamnosus-treated OA rats, the expression levels of Monocyte chemoattractant protein-<italic>1 (</italic>MCP-1<italic>)</italic> and its receptors Recombinant Chemokine C-C-Motif Receptor 2 (CCR2), interleukin-1&#x003B2; (IL-1&#x003B2;), matrix metallopeptidase 3 (MMP3) were decreased, while &#x003B3;-aminobutyric acid (GABA) and peroxisome proliferator-activated receptor &#x003B3; (PPAR-&#x003B3;), tissue inhibitor of metalloproteinases 1 (TIMP1), tissue inhibitor of metalloproteinases 3 (TIMP3), SRY-related high mobility group-box gene9 (SOX9) and Type II collagen fiber &#x003B1;1 gene (COL2A1) and interleukin-10 (IL-10) increased expression levels (<xref ref-type="bibr" rid="B27">27</xref>).</p></sec>
<sec>
<title>The effect of inflammation on OA</title>
<p>Inflammation is a key link in the occurrence and development of OA. Whether it is inflammation in the plasma or in the local soft tissue of the joint, it can cause OA. Studies have shown that stimulation of toll-like receptor (TLR) signaling can exacerbate invasive OA in mice (<xref ref-type="bibr" rid="B29">29</xref>). At the same time, serum high-sensitivity C-reactive protein (hs-CRP) levels were correlated with bone and joint WOMAC score and VAS score (<xref ref-type="bibr" rid="B31">31</xref>). Research has shown that, LPS and lipopolysaccharide-binding protein (LBP) were significantly associated with activated macrophages and osteophyte severity in the joints of Knee Osteoarthritis (KOA) patients (<xref ref-type="bibr" rid="B30">30</xref>). Guan et al. also reported that the main indicators of OA, bone volume over total volume (BV/TV), trabecular thickness (Tb.Th), and medial femoral condyle (MFC) were positively correlated with LPS, IL-6, and Tumor necrosis factor-&#x003B1; (TNF-&#x003B1;), and negatively correlated with the ratio of Firmicutes and Bacteroidetes (<xref ref-type="bibr" rid="B25">25</xref>). However, not all studies have shown a correlation between inflammatory markers and osteoarthritis. Studies have shown no statistically significant association between soluble Toll-like receptor 4 (sTLR4) or IL-6 and radiographic progression of OA (<xref ref-type="bibr" rid="B32">32</xref>).</p></sec></sec>
<sec id="s4">
<title>Discussions</title>
<p>Our systematic review suggests a link between low-grade inflammation caused by gut microbiota and osteoarthritis, but further research is needed in the future. Low-grade inflammation leads to OA through the production of inflammatory mediators, including innate immune activation, macrophage-dominated inflammatory response, Toll-like receptor (TLR) activation, and complement activation, among which TLR signaling plays an important role in the pathogenesis of OA (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B36">36</xref>&#x02013;<xref ref-type="bibr" rid="B38">38</xref>). Locally injured molecules activate TLRs, which trigger the secretion of pro-inflammatory substances and local inflammation in the joints (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B38">38</xref>). It has been found that TLR expression is increased in areas of cartilage damage in OA patients (<xref ref-type="bibr" rid="B39">39</xref>). Upregulation of various TLR signaling components is seen in OA-associated chondrocytes, most notably LBP and cluster of differentiation 14 (CD14), which are accessory proteins of multiple TLRs and interact with multiple signaling molecules including LPS (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>).</p>
<p>Studies have shown that gut bacterial products such as LPS can enter the systemic circulation and affect many organs, including joints, by causing systemic low-grade inflammation (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B40">40</xref>). LPS is an endotoxin associated with the outer membrane of various Gram-negative pathogens (<xref ref-type="bibr" rid="B41">41</xref>) and a classic innate immune system activator that activates host immune cells by binding to Toll-like proteins. Meanwhile, a correlation study between LPS and OA has shown that human serum LPS levels are associated with osteophyte severity in OA, and synovial fluid LPS is associated with osteophyte severity, joint space narrowing, and total pain/function severity scores (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>Similar to LPS, LBP has also been shown to be associated with increased KOA severity in humans (<xref ref-type="bibr" rid="B30">30</xref>). LBP is mainly produced by hepatocytes and is a well-known acute phase reactant (<xref ref-type="bibr" rid="B42">42</xref>). LBP is activated by inflammatory mediators such as IL-6 and directly or indirectly by LPS itself (<xref ref-type="bibr" rid="B43">43</xref>&#x02013;<xref ref-type="bibr" rid="B45">45</xref>). In humans, LBP triggers a dynamic endotoxin cascade by binding LPS and transferring it to CD14, which transfers LPS to the Toll-like receptor 4-myeloid differentiation protein-2 (TLR4-MD-2) receptor on immune cells; LBP thereby concentrates LPS on the cell membrane of immune cells, to induce an inflammatory response (<xref ref-type="bibr" rid="B46">46</xref>). LBP binds pro-inflammatory components of both Gram-positive and Gram-negative bacteria (<xref ref-type="bibr" rid="B47">47</xref>), making it a more prevalent marker of bacterial exposure than LPS derived only from Gram-negative bacteria (<xref ref-type="bibr" rid="B45">45</xref>). Meanwhile, other studies have shown that LBP is necessary for the inflammatory cascade triggered by saturated fatty acids and metabolic endotoxemia (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>).</p>
<p>A high-fat diet, an unhealthy dietary pattern that leads to obesity, altering microbial community structure and reduce microbial diversity, resulting in an increase in pro-inflammatory microbiota, thereby increasing intestinal permeability and circulating levels of LPS. In a high-fat diet model, TLR signaling plays a key role in low-grade inflammatory pathways (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B50">50</xref>), such as toll-like receptor 4 (TLR4) (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>), LPS, and LBP (<xref ref-type="bibr" rid="B31">31</xref>), and interleukin 6 (IL-6) (<xref ref-type="bibr" rid="B53">53</xref>&#x02013;<xref ref-type="bibr" rid="B55">55</xref>), and have also been implicated in the inflammatory mechanisms of OA.</p>
<p>Exercise diversifies the gut microbiota and reduces the Firmicutes/Bacteroidetes ratio (<xref ref-type="bibr" rid="B56">56</xref>). This view was validated in our systematic review (<xref ref-type="bibr" rid="B28">28</xref>). At the same time, exercise produces high levels of endocannabinoids in arthritis patients, which mediate the gut microbiota to produce anti-inflammatory substances that reduce pain (<xref ref-type="bibr" rid="B57">57</xref>).</p>
<p>Gender variance is one of the factors affecting the prevalence of OA. A meta-analysis on global incidence and prevalence of OA in women is 1.69 and 1.39 times as much in males, respectively (<xref ref-type="bibr" rid="B58">58</xref>). Meanwhile, a study found that polymorphism in growth differentiation factor-5, estrogen-specific receptor-alpha, and calmodulin-1 has increased the disruption of cartilage and reduced mRNA and protein synthesis, which increased the risk of KOA in women (<xref ref-type="bibr" rid="B59">59</xref>). Moreover, A prevalence study on osteoporosis, hypovitaminosis D, and OA found higher rates of Vitamin D insufficiency and deficiency in women than in men (<xref ref-type="bibr" rid="B60">60</xref>), and there is a correlation between vitamin D deficiency and OA (<xref ref-type="bibr" rid="B61">61</xref>).</p></sec>
<sec id="s5">
<title>Limitations</title>
<p>First, In the analysis of microbial sequencing, the analytical methods were different across studies involving various regions (V3-V5) and cut-off points for clustering OTUs which may affect the results. Second, the gut microbial community analysis by 16S rRNA sequencing was not used in all studies, which may affect the consistency of the results. Third, most of them are animal studies, and there are fewer extensive studies in humans, and fewer studies on the complexity of the gut microbiota and its association with OA. Finally, most studies have only observed changes in gut microbiota and inflammatory factors, but the underlying mechanisms have not been further explored.</p></sec>
<sec sec-type="conclusions" id="s6">
<title>Conclusions</title>
<p>In conclusion, our systematic review provides evidence for the development of OA due to low-grade inflammation caused by intestinal flora disturbance. Further studies are needed to explore the mechanisms involved.</p></sec>
<sec sec-type="data-availability" id="s7">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary material</xref>, further inquiries can be directed to the corresponding author/s.</p></sec>
<sec id="s8">
<title>Author contributions</title>
<p>WX and HX conceived and designed research, performed experiments, and edited and revised manuscript. YJ analyzed data. BJ and YJ interpreted results of experiments. WX prepared figures and drafted manuscript. All authors contributed to the article and approved the submitted version.</p></sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>This study was supported by the Chongqing Beibei District Science and Technology Bureau Project (2022-18).</p></sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
</body>
<back><sec sec-type="supplementary-material" id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fvets.2022.938629/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fvets.2022.938629/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.DOCX" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_3.DOCX" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_4.DOCX" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kassebaum</surname> <given-names>NJ</given-names></name> <name><surname>Arora</surname> <given-names>M</given-names></name> <name><surname>Barber</surname> <given-names>RM</given-names></name> <name><surname>Bhutta</surname> <given-names>ZA</given-names></name> <name><surname>Brown</surname> <given-names>J</given-names></name> <name><surname>Carter</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015</article-title>. <source>Lancet.</source> (<year>2016</year>) <volume>388</volume>:<fpage>1603</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)31460-X</pub-id><pub-id pub-id-type="pmid">27733283</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guilak</surname> <given-names>F</given-names></name></person-group>. <article-title>Biomechanical factors in osteoarthritis</article-title>. <source>Best Pract Res Clin Rheumatol.</source> (<year>2011</year>) <volume>25</volume>:<fpage>815</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.berh.2011.11.013</pub-id><pub-id pub-id-type="pmid">22265263</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panoutsopoulou</surname> <given-names>K</given-names></name> <name><surname>Zeggini</surname> <given-names>E</given-names></name></person-group>. <article-title>Advances in osteoarthritis genetics</article-title>. <source>J Med Genet.</source> (<year>2013</year>) <volume>50</volume>:<fpage>715</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2013-101754</pub-id><pub-id pub-id-type="pmid">23868913</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>WH</given-names></name> <name><surname>Lepus</surname> <given-names>CM</given-names></name> <name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Raghu</surname> <given-names>H</given-names></name> <name><surname>Mao</surname> <given-names>R</given-names></name> <name><surname>Lindstrom</surname> <given-names>TM</given-names></name> <etal/></person-group>. <article-title>Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis</article-title>. <source>Nat Rev Rheumatol.</source> (<year>2016</year>) <volume>12</volume>:<fpage>580</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2016.136</pub-id><pub-id pub-id-type="pmid">27539668</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boer</surname> <given-names>CG</given-names></name> <name><surname>Radjabzadeh</surname> <given-names>D</given-names></name> <name><surname>Gomez</surname> <given-names>CM</given-names></name> <name><surname>Garmaeva</surname> <given-names>S</given-names></name> <name><surname>Schiphof</surname> <given-names>D</given-names></name> <name><surname>Arp</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Intestinal microbiome composition and its relation to joint pain and inflammation</article-title>. <source>Nat Commun.</source> (<year>2019</year>) <volume>10</volume>:<fpage>4881</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-12873-4</pub-id><pub-id pub-id-type="pmid">31653850</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rothschild</surname> <given-names>D</given-names></name> <name><surname>Weissbrod</surname> <given-names>O</given-names></name> <name><surname>Barkan</surname> <given-names>E</given-names></name> <name><surname>Kurilshikov</surname> <given-names>A</given-names></name> <name><surname>Korem</surname> <given-names>T</given-names></name> <name><surname>Zeevi</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Environment dominates over host genetics in shaping human gut microbiota</article-title>. <source>Nature.</source> (<year>2018</year>) <volume>555</volume>:<fpage>210</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/nature25973</pub-id><pub-id pub-id-type="pmid">29489753</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname> <given-names>A</given-names></name> <name><surname>Mitchell</surname> <given-names>AL</given-names></name> <name><surname>Boland</surname> <given-names>M</given-names></name> <name><surname>Forster</surname> <given-names>SC</given-names></name> <name><surname>Gloor</surname> <given-names>GB</given-names></name> <name><surname>Tarkowska</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>A new genomic blueprint of the human gut microbiota</article-title>. <source>Nature.</source> (<year>2019</year>) <volume>568</volume>:<fpage>499</fpage>&#x02013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-0965-1</pub-id><pub-id pub-id-type="pmid">30745586</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Ley</surname> <given-names>RE</given-names></name> <name><surname>Peterson</surname> <given-names>DA</given-names></name> <name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group>. <article-title>Ecological and evolutionary forces shaping microbial diversity in the human intestine</article-title>. <source>Cell</source>. (<year>2006</year>) <volume>124</volume>:<fpage>837</fpage>-<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.02.017</pub-id><pub-id pub-id-type="pmid">16497592</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname> <given-names>SV</given-names></name> <name><surname>Pedersen</surname> <given-names>O</given-names></name></person-group>. <article-title>The Human Intestinal Microbiome in Health and Disease</article-title>. <source>N Engl J Med.</source> (<year>2016</year>) <volume>375</volume>:<fpage>2369</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1600266</pub-id><pub-id pub-id-type="pmid">32675857</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname> <given-names>DN</given-names></name> <name><surname>Amand</surname> <given-names>AL</given-names></name> <name><surname>St Robert</surname> <given-names>A</given-names></name> <name><surname>Feldman</surname> <given-names>RA</given-names></name> <name><surname>Boedeker</surname> <given-names>EC</given-names></name> <name><surname>Harpaz</surname> <given-names>N</given-names></name> <name><surname>Pace</surname> <given-names>N N R</given-names></name></person-group> <article-title>Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2007</year>) <volume>104</volume>:<fpage>13780</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0706625104</pub-id><pub-id pub-id-type="pmid">17699621</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname> <given-names>EA</given-names></name> <name><surname>Tillisch</surname> <given-names>K</given-names></name> <name><surname>Gupta</surname> <given-names>A</given-names></name></person-group>. <article-title>Gut/brain axis and the microbiota</article-title>. <source>J Clin Invest.</source> (<year>2015</year>) <volume>125</volume>:<fpage>926</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1172/JCI76304</pub-id><pub-id pub-id-type="pmid">25689247</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kau</surname> <given-names>AL</given-names></name> <name><surname>Ahern</surname> <given-names>PP</given-names></name> <name><surname>Griffin</surname> <given-names>NW</given-names></name> <name><surname>Goodman</surname> <given-names>AL</given-names></name> <name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group>. <article-title>Human nutrition, the gut microbiome and the immune system</article-title>. <source>Nature.</source> (<year>2011</year>) <volume>474</volume>:<fpage>327</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/nature10213</pub-id><pub-id pub-id-type="pmid">21677749</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname> <given-names>JK</given-names></name> <name><surname>Holmes</surname> <given-names>E</given-names></name> <name><surname>Kinross</surname> <given-names>J</given-names></name> <name><surname>Burcelin</surname> <given-names>R</given-names></name> <name><surname>Gibson</surname> <given-names>G</given-names></name> <name><surname>Jia</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Host-gut microbiota metabolic interactions</article-title>. <source>Science.</source> (<year>2012</year>) <volume>336</volume>:<fpage>1262</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1126/science.1223813</pub-id><pub-id pub-id-type="pmid">22674330</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blander</surname> <given-names>JM</given-names></name> <name><surname>Longman</surname> <given-names>RS</given-names></name> <name><surname>Iliev</surname> <given-names>ID</given-names></name> <name><surname>Sonnenberg</surname> <given-names>GF</given-names></name> <name><surname>Artis</surname> <given-names>D</given-names></name></person-group>. <article-title>Regulation of inflammation by microbiota interactions with the host</article-title>. <source>Nat Immunol.</source> (<year>2017</year>) <volume>18</volume>:<fpage>851</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3780</pub-id><pub-id pub-id-type="pmid">28722709</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sartor</surname> <given-names>RB</given-names></name> <name><surname>Wu</surname> <given-names>GD</given-names></name></person-group>. <article-title>Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches</article-title>. <source>Gastroenterology.</source> (<year>2017</year>) <volume>152</volume>:<fpage>327</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2016.10.012</pub-id><pub-id pub-id-type="pmid">27769810</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berenbaum</surname> <given-names>F</given-names></name> <name><surname>Griffin</surname> <given-names>TM</given-names></name> <name><surname>Liu-Bryan</surname> <given-names>R</given-names></name></person-group>. <article-title>Review: metabolic regulation of inflammation in osteoarthritis</article-title>. <source>Arthritis Rheumatol.</source> (<year>2017</year>) <volume>69</volume>:<fpage>9</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/art.39842</pub-id><pub-id pub-id-type="pmid">27564539</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krasnokutsky</surname> <given-names>S</given-names></name> <name><surname>Oshinsky</surname> <given-names>C</given-names></name> <name><surname>Attur</surname> <given-names>M</given-names></name> <name><surname>Ma</surname> <given-names>S</given-names></name> <name><surname>Zhou</surname> <given-names>H</given-names></name> <name><surname>Zheng</surname> <given-names>FF</given-names></name> <etal/></person-group>. <article-title>Serum urate levels predict joint space narrowing in non-gout patients with medial knee osteoarthritis</article-title>. <source>Arthritis Rheumatol.</source> (<year>2017</year>) <volume>69</volume>:<fpage>1213</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/art.40069</pub-id><pub-id pub-id-type="pmid">28217895</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname> <given-names>JA</given-names></name> <name><surname>Hern&#x000E1;n</surname> <given-names>HA</given-names></name> <name><surname>Reeves</surname> <given-names>BC</given-names></name> <name><surname>Savovi&#x00107;</surname> <given-names>J</given-names></name> <name><surname>Berkman</surname> <given-names>ND</given-names></name> <name><surname>Viswanathan</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions</article-title>. <source>BMJ.</source> (<year>2016</year>) <volume>355</volume>:<fpage>i4919</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.i4919</pub-id><pub-id pub-id-type="pmid">27733354</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname> <given-names>JAC</given-names></name> <name><surname>Savovi&#x00107;</surname> <given-names>J</given-names></name> <name><surname>Page</surname> <given-names>MJ</given-names></name> <name><surname>Elbers</surname> <given-names>RG</given-names></name> <name><surname>Blencowe</surname> <given-names>NS</given-names></name> <name><surname>Boutron</surname> <given-names>I</given-names></name> <etal/></person-group>. <article-title>RoB 2: a revised tool for assessing risk of bias in randomised trials</article-title>. <source>BMJ.</source> (<year>2019</year>) <volume>366</volume>:<fpage>14898</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.l4898</pub-id><pub-id pub-id-type="pmid">31462531</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hooijmans</surname> <given-names>CR</given-names></name> <name><surname>Rovers</surname> <given-names>MM</given-names></name> <name><surname>Vries</surname> <given-names>RBD</given-names></name> <name><surname>Leenaars</surname> <given-names>M</given-names></name> <name><surname>Hoitinga</surname> <given-names>MR</given-names></name> <name><surname>Langendam</surname> <given-names>MW</given-names></name> <etal/></person-group>. <article-title>SYRCLE&#x00027;s risk of bias tool for animal studies</article-title>. <source>BMC Med Res Methodol.</source> (<year>2014</year>) <volume>14</volume>:<fpage>43</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2288-14-43</pub-id><pub-id pub-id-type="pmid">24667063</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guyatt</surname> <given-names>GH</given-names></name> <name><surname>Oxman</surname> <given-names>AD</given-names></name> <name><surname>Schunemann</surname> <given-names>HJ</given-names></name> <name><surname>Tugwell</surname> <given-names>P</given-names></name> <name><surname>Knottnerus</surname> <given-names>AGRADE</given-names></name></person-group>. <article-title>guidelines: a new series of articles in the Journal of Clinical Epidemiology</article-title>. <source>J Clin Epidemiol.</source> (<year>2011</year>) <volume>64</volume>:<fpage>380</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.09.011</pub-id><pub-id pub-id-type="pmid">21185693</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macleod</surname> <given-names>MR</given-names></name> <name><surname>O&#x00027;Collins</surname> <given-names>T</given-names></name> <name><surname>Howells</surname> <given-names>DW</given-names></name> <name><surname>Donnan</surname> <given-names>GA</given-names></name></person-group>. <article-title>Pooling of animal experimental data reveals influence of study design and publication bias</article-title>. <source>Stroke.</source> (<year>2004</year>) <volume>35</volume>:<fpage>1203</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.0000125719.25853.20</pub-id><pub-id pub-id-type="pmid">15060322</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Landis</surname> <given-names>SC</given-names></name> <name><surname>Amara</surname> <given-names>SG</given-names></name> <name><surname>Asadullah</surname> <given-names>K</given-names></name> <name><surname>Austin</surname> <given-names>CP</given-names></name> <name><surname>Blumenstein</surname> <given-names>P</given-names></name> <name><surname>Bradley</surname> <given-names>EW</given-names></name> <etal/></person-group>. <article-title>A call for transparent reporting to optimize the predictive value of preclinical research</article-title>. <source>Nature.</source> (<year>2012</year>) <volume>490</volume>:<fpage>187</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/nature11556</pub-id><pub-id pub-id-type="pmid">23060188</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ulici</surname> <given-names>V</given-names></name> <name><surname>Kelley</surname> <given-names>KL</given-names></name> <name><surname>Azcarate-Peril</surname> <given-names>MA</given-names></name> <name><surname>Cleveland</surname> <given-names>RJ</given-names></name> <name><surname>Sartor</surname> <given-names>RB</given-names></name> <name><surname>Schwartz</surname> <given-names>TA</given-names></name> <etal/></person-group>. <article-title>Osteoarthritis induced by destabilization of the medial meniscus is reduced in germ-free mice</article-title>. <source>Osteoarthritis Cartilage.</source> (<year>2018</year>) <volume>26</volume>:<fpage>1098</fpage>&#x02013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2018.05.016</pub-id><pub-id pub-id-type="pmid">29857156</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname> <given-names>Z</given-names></name> <name><surname>Jia</surname> <given-names>JL</given-names></name> <name><surname>Zhang</surname> <given-names>CG</given-names></name> <name><surname>Sun</surname> <given-names>TT</given-names></name> <name><surname>Zhang</surname> <given-names>W</given-names></name> <name><surname>Yuan</surname> <given-names>WQ</given-names></name> <etal/></person-group>. <article-title>Gut microbiome dysbiosis alleviates the progression of osteoarthritis in mice</article-title>. <source>Clin Sci (Lond).</source> (<year>2020</year>) <volume>134</volume>:<fpage>3159</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1042/CS20201224</pub-id><pub-id pub-id-type="pmid">33215637</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Z</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>BL</given-names></name> <name><surname>Zeng</surname> <given-names>BH</given-names></name> <name><surname>Chou</surname> <given-names>CH</given-names></name> <name><surname>Zheng</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice</article-title>. <source>Ann Rheum Dis.</source> (<year>2020</year>) <volume>79</volume>:<fpage>646</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2019-216471</pub-id><pub-id pub-id-type="pmid">32205337</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jhun</surname> <given-names>J</given-names></name> <name><surname>Cho</surname> <given-names>KH</given-names></name> <name><surname>Lee</surname> <given-names>DH</given-names></name> <name><surname>Kwon</surname> <given-names>JY</given-names></name> <name><surname>Woo</surname> <given-names>JS</given-names></name> <name><surname>Kim</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Oral administration of lactobacillus rhamnosus ameliorates the progression of osteoarthritis by inhibiting joint pain and inflammation</article-title>. <source>Cells.</source> (<year>2021</year>) <volume>10</volume>:<fpage>1057</fpage>. <pub-id pub-id-type="doi">10.3390/cells10051057</pub-id><pub-id pub-id-type="pmid">33946919</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>K</given-names></name> <name><surname>Liu</surname> <given-names>AL</given-names></name> <name><surname>Zong</surname> <given-names>WH</given-names></name> <name><surname>Dai</surname> <given-names>LL</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Luo</surname> <given-names>RP</given-names></name> <etal/></person-group>. <article-title>Moderate exercise ameliorates osteoarthritis by reducing lipopolysaccharides from gut microbiota in mice</article-title>. <source>Saudi J Biol Sci.</source> (<year>2021</year>) <volume>28</volume>:<fpage>40</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.sjbs.2020.08.027</pub-id><pub-id pub-id-type="pmid">33424281</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Won</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>JI</given-names></name> <name><surname>Park</surname> <given-names>S</given-names></name> <name><surname>Chun</surname> <given-names>JS</given-names></name></person-group>. <article-title>Lipopolysaccharide binding protein and CD14, cofactors of toll-like receptors, are essential for low-grade inflammation-induced exacerbation of cartilage damage in mouse models of posttraumatic osteoarthritis</article-title>. <source>Arthritis Rheumatol.</source> (<year>2021</year>) <volume>73</volume>:<fpage>1451</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1002/art.41679</pub-id><pub-id pub-id-type="pmid">33559324</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>ZY</given-names></name> <name><surname>Stabler</surname> <given-names>T</given-names></name> <name><surname>Pei</surname> <given-names>FX</given-names></name> <name><surname>Kraus</surname> <given-names>VB</given-names></name></person-group>. <article-title>Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation</article-title>. <source>Osteoarthritis Cartilage.</source> (<year>2016</year>) <volume>24</volume>:<fpage>1769</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2016.05.008</pub-id><pub-id pub-id-type="pmid">27216281</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname> <given-names>M</given-names></name> <name><surname>Guo</surname> <given-names>C</given-names></name> <name><surname>Wang</surname> <given-names>D</given-names></name> <name><surname>Zhang</surname> <given-names>C</given-names></name> <name><surname>Hua</surname> <given-names>L</given-names></name></person-group>. <article-title>The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial</article-title>. <source>Benef Microbes.</source> (<year>2017</year>) <volume>8</volume>:<fpage>697</fpage>&#x02013;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.3920/BM2016.0207</pub-id><pub-id pub-id-type="pmid">28726510</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>ZY</given-names></name> <name><surname>Perry</surname> <given-names>E</given-names></name> <name><surname>Huebner</surname> <given-names>JL</given-names></name> <name><surname>Katz</surname> <given-names>B</given-names></name> <name><surname>Li</surname> <given-names>YJ</given-names></name> <name><surname>Kraus</surname> <given-names>VB</given-names></name> <etal/></person-group>. <article-title>Biomarkers of inflammation&#x02014;LBP and TLR- predict progression of knee osteoarthritis in the DOXY clinical trial</article-title>. <source>Osteoarthritis Cartilage.</source> (<year>2018</year>) <volume>26</volume>:<fpage>1658</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2018.08.005</pub-id><pub-id pub-id-type="pmid">30144513</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname> <given-names>CM</given-names></name> <name><surname>Velasco</surname> <given-names>C</given-names></name> <name><surname>Rivas</surname> <given-names>A</given-names></name> <name><surname>Andrews</surname> <given-names>M</given-names></name> <name><surname>Garman</surname> <given-names>C</given-names></name> <name><surname>Jacob</surname> <given-names>PB</given-names></name> <etal/></person-group>. <article-title>Identification of cartilage microbial DNA signatures and associations with knee and hip osteoarthritis</article-title>. <source>Arthritis Rheumatol.</source> (<year>2020</year>) <volume>72</volume>:<fpage>1111</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1002/art.41210</pub-id><pub-id pub-id-type="pmid">31961065</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loeser</surname> <given-names>RF</given-names></name> <name><surname>Arbeeva</surname> <given-names>L</given-names></name> <name><surname>Kelley</surname> <given-names>K</given-names></name> <name><surname>Fodor</surname> <given-names>AA</given-names></name> <name><surname>Sun</surname> <given-names>S</given-names></name> <name><surname>Ulici</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>Association of increased serum lipopolysaccharide, but not microbial dysbiosis, with obesity-related osteoarthritis</article-title>. <source>Arthritis Rheumatol.</source> (<year>2022</year>) <volume>74</volume>:<fpage>227</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1002/art.41955</pub-id><pub-id pub-id-type="pmid">34423918</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rios</surname> <given-names>JL</given-names></name> <name><surname>Bomhof</surname> <given-names>MR</given-names></name> <name><surname>Reimer</surname> <given-names>RA</given-names></name> <name><surname>Hart</surname> <given-names>DA</given-names></name> <name><surname>Collins</surname> <given-names>KH</given-names></name> <name><surname>Herzog</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Protective effect of prebiotic and exercise intervention on knee health in a rat model of diet-induced obesity</article-title>. <source>Sci Rep.</source> (<year>2019</year>) <volume>9</volume>:<fpage>3893</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-40601-x</pub-id><pub-id pub-id-type="pmid">30846801</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>CC</given-names></name> <name><surname>Avalos</surname> <given-names>AM</given-names></name> <name><surname>Ploegh</surname> <given-names>HL</given-names></name></person-group>. <article-title>Accessory molecules for Toll-like receptors and their function</article-title>. <source>Nat Rev Immunol.</source> (<year>2012</year>) <volume>12</volume>:<fpage>168</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1038/nri3151</pub-id><pub-id pub-id-type="pmid">22301850</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname> <given-names>R</given-names></name> <name><surname>Villalvilla</surname> <given-names>A</given-names></name> <name><surname>Largo</surname> <given-names>R</given-names></name> <name><surname>Gualillo</surname> <given-names>O</given-names></name> <name><surname>Herrero-Beaumont</surname> <given-names>G</given-names></name></person-group>. <article-title>TLR4 signalling in osteoarthritis&#x02013;finding targets for candidate DMOADs</article-title>. <source>Nat Rev Rheumatol.</source> (<year>2015</year>) <volume>11</volume>:<fpage>159</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2014.209</pub-id><pub-id pub-id-type="pmid">25512010</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van den Bosch</surname> <given-names>MHJ</given-names></name> <name><surname>van Lent</surname> <given-names>P</given-names></name> <name><surname>van der Kraan</surname> <given-names>PM</given-names></name></person-group>. <article-title>Identifying effector molecules, cells, and cytokines of innate immunity in OA</article-title>. <source>Osteoarthritis Cartilage.</source> (<year>2020</year>) <volume>28</volume>:<fpage>532</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2020.01.016</pub-id><pub-id pub-id-type="pmid">32044352</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>HA</given-names></name> <name><surname>Cho</surname> <given-names>ML</given-names></name> <name><surname>Choi</surname> <given-names>HY</given-names></name> <name><surname>Yoon</surname> <given-names>CS</given-names></name> <name><surname>Jhun</surname> <given-names>JY</given-names></name> <name><surname>Kim</surname> <given-names>HY</given-names></name> <etal/></person-group>. <article-title>The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes</article-title>. <source>Arthritis Rheum.</source> (<year>2006</year>) <volume>54</volume>:<fpage>2152</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1002/art.21951</pub-id><pub-id pub-id-type="pmid">16802353</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Creely</surname> <given-names>SJ</given-names></name> <name><surname>McTernan</surname> <given-names>PG</given-names></name> <name><surname>Kusminski</surname> <given-names>CM</given-names></name> <name><surname>Fisherff</surname> <given-names>M</given-names></name> <name><surname>Silva</surname> <given-names>NF</given-names></name> <name><surname>Da Khanolkar</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes</article-title>. <source>Am J Physiol Endocrinol Metab</source>. (<year>2007</year>) <volume>292</volume>:<fpage>E740</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00302.2006</pub-id><pub-id pub-id-type="pmid">17090751</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>SI</given-names></name> <name><surname>Ernst</surname> <given-names>RK</given-names></name> <name><surname>Bader</surname> <given-names>MWLPS</given-names></name></person-group>. <article-title>TLR4 and infectious disease diversity</article-title>. <source>Nat Rev Microbiol.</source> (<year>2005</year>) <volume>3</volume>:<fpage>36</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1068</pub-id><pub-id pub-id-type="pmid">15608698</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schumann</surname> <given-names>R</given-names></name> <name><surname>Kirsching</surname> <given-names>CJ</given-names></name> <name><surname>Lamping</surname> <given-names>N</given-names></name> <name><surname>Amping</surname> <given-names>N</given-names></name> <name><surname>Mping</surname> <given-names>N</given-names></name> <name><surname>Unbehaun</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT-3 and other cytokine-inducible nuclear proteins</article-title>. <source>Mol Cell Biol</source>. (<year>1996</year>) <volume>16</volume>:<fpage>3490</fpage>&#x02013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.16.7.3490</pub-id><pub-id pub-id-type="pmid">8668165</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brass</surname> <given-names>DM</given-names></name> <name><surname>Savov</surname> <given-names>JD</given-names></name> <name><surname>Whitehead</surname> <given-names>GS</given-names></name> <name><surname>Maxwell</surname> <given-names>AB</given-names></name> <name><surname>Schwartz</surname> <given-names>DA</given-names></name></person-group>. <article-title>LPS binding protein is important in the airway response to inhaled endotoxin</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2004</year>) <volume>114</volume>:<fpage>586</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2004.04.043</pub-id><pub-id pub-id-type="pmid">15356561</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gamble</surname> <given-names>L</given-names></name> <name><surname>Bagby</surname> <given-names>GJ</given-names></name> <name><surname>Quinton</surname> <given-names>LJ</given-names></name> <name><surname>Happel KI</surname> <given-names>JP</given-names></name> <name><surname>Zhang</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>The systemic and pulmonary LPS binding protein response to intratracheal lipopolysaccharide</article-title>. <source>Shock.</source> (<year>2009</year>) <volume>31</volume>:<fpage>212</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/SHK.0b013e31817c0d7d</pub-id><pub-id pub-id-type="pmid">18520704</pub-id></citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schumann</surname> <given-names>RR</given-names></name></person-group>. <article-title>Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule</article-title>. <source>Biochem Soc Trans.</source> (<year>2011</year>) <volume>39</volume>:<fpage>989</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1042/BST0390989</pub-id><pub-id pub-id-type="pmid">21787335</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>BS</given-names></name> <name><surname>Lee</surname> <given-names>JO</given-names></name></person-group>. <article-title>Recognition of lipopolysaccharide pattern by TLR4 complexes</article-title>. <source>Exp Mol Med.</source> (<year>2013</year>) <volume>45</volume>:<fpage>e66</fpage>. <pub-id pub-id-type="doi">10.1038/emm.2013.97</pub-id><pub-id pub-id-type="pmid">24310172</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>Y</given-names></name> <name><surname>Kagan</surname> <given-names>JCA</given-names></name></person-group>. <article-title>cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide</article-title>. <source>Mol Cell.</source> (<year>2014</year>) <volume>54</volume>:<fpage>212</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.012</pub-id><pub-id pub-id-type="pmid">24766885</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>S</given-names></name> <name><surname>LaPoint</surname> <given-names>K</given-names></name> <name><surname>Martinez</surname> <given-names>M</given-names></name> <name><surname>Kennedy</surname> <given-names>A</given-names></name> <name><surname>Sandberg</surname> <given-names>MB</given-names></name> <name><surname>McIntosh</surname> <given-names>MK</given-names></name></person-group>. <article-title>Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes</article-title>. <source>Endocrinology.</source> (<year>2006</year>) <volume>147</volume>:<fpage>5340</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1210/en.2006-0536</pub-id><pub-id pub-id-type="pmid">16873530</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cani</surname> <given-names>PD</given-names></name> <name><surname>Amar</surname> <given-names>J</given-names></name> <name><surname>Iglesias</surname> <given-names>MA</given-names></name> <name><surname>Poggi</surname> <given-names>M</given-names></name> <name><surname>Knauf</surname> <given-names>C</given-names></name> <name><surname>Bastelica</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Metabolic endotoxemia initiates obesity and insulin resistance</article-title>. <source>Diabetes.</source> (<year>2007</year>) <volume>56</volume>:<fpage>1761</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.2337/db06-1491</pub-id><pub-id pub-id-type="pmid">18042755</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sansone</surname> <given-names>V</given-names></name> <name><surname>Applefield</surname> <given-names>RC</given-names></name> <name><surname>Luca</surname> <given-names>PD</given-names></name> <name><surname>Pecoraro</surname> <given-names>V</given-names></name> <name><surname>Gianola</surname> <given-names>S</given-names></name> <name><surname>Pascale</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Does a high-fat diet affect the development and progression of osteoarthritis in mice?</article-title> <source>Bone Joint Res.</source> (<year>2020</year>) <volume>8</volume>:<fpage>582</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1302/2046-3758.812.BJR-2019-0038.R1</pub-id><pub-id pub-id-type="pmid">31934329</pub-id></citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barret</surname> <given-names>G</given-names></name> <name><surname>Soininen</surname> <given-names>A</given-names></name> <name><surname>Ylinen</surname> <given-names>P</given-names></name> <name><surname>Sandelin</surname> <given-names>J</given-names></name> <name><surname>Konttinen</surname> <given-names>YT</given-names></name> <name><surname>Nordstr&#x000F6;m</surname> <given-names>DC</given-names></name> <etal/></person-group>. <article-title>Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis</article-title>. <source>Arthritis Res Ther.</source> (<year>2015</year>) <volume>17</volume>:<fpage>379</fpage>. <pub-id pub-id-type="doi">10.1186/s13075-015-0902-0</pub-id><pub-id pub-id-type="pmid">26703441</pub-id></citation></ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abella</surname> <given-names>V</given-names></name> <name><surname>Scotece</surname> <given-names>M</given-names></name> <name><surname>Conde</surname> <given-names>J</given-names></name> <name><surname>L&#x000F3;pez</surname> <given-names>V</given-names></name> <name><surname>Pirozzi</surname> <given-names>C</given-names></name> <name><surname>Pino</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>20356</fpage>. <pub-id pub-id-type="doi">10.1038/srep20356</pub-id><pub-id pub-id-type="pmid">26853108</pub-id></citation></ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noss</surname> <given-names>EH</given-names></name> <name><surname>Nguyen</surname> <given-names>HN</given-names></name> <name><surname>Chang</surname> <given-names>SK</given-names></name> <name><surname>Watts</surname> <given-names>GF</given-names></name> <name><surname>Brenner</surname> <given-names>MB</given-names></name></person-group>. <article-title>Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2015</year>) <volume>112</volume>:<fpage>14948</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1520861112</pub-id><pub-id pub-id-type="pmid">26578807</pub-id></citation></ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Latourte</surname> <given-names>A</given-names></name> <name><surname>Cherifi</surname> <given-names>C</given-names></name> <name><surname>Maillet</surname> <given-names>J</given-names></name> <name><surname>Ea</surname> <given-names>HK</given-names></name> <name><surname>Bouaziz</surname> <given-names>W</given-names></name> <name><surname>Funck-Brentano</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis</article-title>. <source>Ann Rheum Dis.</source> (<year>2017</year>) <volume>76</volume>:<fpage>748</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2016-209757</pub-id><pub-id pub-id-type="pmid">27789465</pub-id></citation></ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radojcic</surname> <given-names>MR</given-names></name> <name><surname>Thudiuma</surname> <given-names>CS</given-names></name> <name><surname>Henriksena</surname> <given-names>K</given-names></name> <name><surname>Tanc</surname> <given-names>K</given-names></name> <name><surname>Karlsten</surname> <given-names>R</given-names></name> <name><surname>Dudley</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Biomarker of extracellular matrix remodelling C1M and proinflammatory cytokine interleukin 6 are related to synovitis and pain in end-stage knee osteoarthritis patients</article-title>. <source>Pain.</source> (<year>2017</year>) <volume>158</volume>:<fpage>1254</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000908</pub-id><pub-id pub-id-type="pmid">28333699</pub-id></citation></ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Codella</surname> <given-names>R</given-names></name> <name><surname>Luzi</surname> <given-names>L</given-names></name> <name><surname>Terruzzi</surname> <given-names>I</given-names></name></person-group>. <article-title>Exercise has the guts: How physical activity may positively modulate gut microbiota in chronic and immune-based diseases</article-title>. <source>Dig Liver Dis.</source> (<year>2018</year>) <volume>50</volume>:<fpage>331</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.dld.2017.11.016</pub-id><pub-id pub-id-type="pmid">29233686</pub-id></citation></ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vijay</surname> <given-names>A</given-names></name> <name><surname>Kouraki</surname> <given-names>A</given-names></name> <name><surname>Gohir</surname> <given-names>S</given-names></name> <name><surname>Turnbull</surname> <given-names>J</given-names></name> <name><surname>Kelly</surname> <given-names>A</given-names></name> <name><surname>Chapman</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids</article-title>. <source>Gut Microbes.</source> (<year>2021</year>) <volume>13</volume>:<fpage>e1997559</fpage>. <pub-id pub-id-type="doi">10.1080/19490976.2021.1997559</pub-id><pub-id pub-id-type="pmid">34787065</pub-id></citation></ref>
<ref id="B58">
<label>58.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>A</given-names></name> <name><surname>Li</surname> <given-names>H</given-names></name> <name><surname>Wang</surname> <given-names>D</given-names></name> <name><surname>Zhong</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Lu</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies?</article-title> <source>EClinicalMedicine</source>. (<year>2020</year>) <volume>26</volume>:<fpage>29</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.eclinm.2020.100587</pub-id><pub-id pub-id-type="pmid">34505846</pub-id></citation></ref>
<ref id="B59">
<label>59.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname> <given-names>A</given-names></name> <name><surname>Srivastava</surname> <given-names>RN</given-names></name> <name><surname>Awasthi</surname> <given-names>S</given-names></name> <name><surname>Parmar</surname> <given-names>D</given-names></name> <name><surname>Mishra</surname> <given-names>P</given-names></name></person-group>. <article-title>Expression of genes and their polymorphism influences the risk of knee osteoarthritis?</article-title> <source>J Nucleic Acids.</source> (<year>2017</year>) <volume>2017</volume>:<fpage>3138254</fpage>. <pub-id pub-id-type="doi">10.1155/2017/3138254</pub-id><pub-id pub-id-type="pmid">29129999</pub-id></citation></ref>
<ref id="B60">
<label>60.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>B</given-names></name> <name><surname>Pal</surname> <given-names>T</given-names></name> <name><surname>Ganguly</surname> <given-names>S</given-names></name> <name><surname>Ghosh</surname> <given-names>AA</given-names></name></person-group>. <article-title>study of the prevalence of osteoporosis and hypovitaminosis D in patients with primary knee osteoarthritis</article-title>. <source>J Clin Orthop Trauma.</source> (<year>2014</year>) <volume>5</volume>:<fpage>199</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcot.2014.09.002</pub-id><pub-id pub-id-type="pmid">25983498</pub-id></citation></ref>
<ref id="B61">
<label>61.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breijawi</surname> <given-names>N</given-names></name> <name><surname>Eckardt</surname> <given-names>A</given-names></name> <name><surname>Pitton</surname> <given-names>MB</given-names></name> <name><surname>Hoelzl</surname> <given-names>AJ</given-names></name> <name><surname>Giesa</surname> <given-names>M</given-names></name> <name><surname>von Stechow</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Bone mineral density and vitamin D status in female and male patients with osteoarthritis of the knee or hip</article-title>. <source>Eur Surg Res</source>. (<year>2009</year>) <volume>42</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1159/000166164</pub-id> <pub-id pub-id-type="pmid">18971579</pub-id></citation></ref>
</ref-list>
</back>
</article>